Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial
Eli Lilly and Company
Richard M Bergenstal; Ruth S Weinstock; Chantal Mathieu; Yukiko Onishi; Vishali Vijayanagaram; Michelle L Katz; Molly C Carr; Annette M Chang